Penumbra, Inc. (NYSE:PEN) investors will be delighted, with the company turning in some strong numbers with its latest results. It was overall a positive result, with revenues beating expectations by 2.7% to hit US$324m. Penumbra also reported a statutory profit of US$1.00, which was an impressive 50% above what the analysts had forecast. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
We've discovered 2 warning signs about Penumbra. View them for free.Taking into account the latest results, the most recent consensus for Penumbra from 20 analysts is for revenues of US$1.35b in 2025. If met, it would imply a meaningful 9.2% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to leap 263% to US$3.96. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$1.35b and earnings per share (EPS) of US$3.63 in 2025. So the consensus seems to have become somewhat more optimistic on Penumbra's earnings potential following these results.
Check out our latest analysis for Penumbra
The consensus price target was unchanged at US$319, implying that the improved earnings outlook is not expected to have a long term impact on value creation for shareholders. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic Penumbra analyst has a price target of US$340 per share, while the most pessimistic values it at US$260. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.
Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. It's pretty clear that there is an expectation that Penumbra's revenue growth will slow down substantially, with revenues to the end of 2025 expected to display 12% growth on an annualised basis. This is compared to a historical growth rate of 18% over the past five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 8.0% annually. So it's pretty clear that, while Penumbra's revenue growth is expected to slow, it's still expected to grow faster than the industry itself.
The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Penumbra's earnings potential next year. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. The consensus price target held steady at US$319, with the latest estimates not enough to have an impact on their price targets.
With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Penumbra analysts - going out to 2027, and you can see them free on our platform here.
You still need to take note of risks, for example - Penumbra has 2 warning signs we think you should be aware of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。